A&D Pharma: Unaudited Financial Statement for the 12 Months Ended 31 December 2009

18% year-on-year RON denominated consolidated sales growth3% year-on-year EUR denominated consolidated sales growth87% year-on-year increase in EUR denominated EBITDA166% year-on-year increase in EUR denominated Operating profit BUCHAREST (Romania), Mar 22, 2010 -- (InPR) -- A&D Pharma Holdings N.V. (the C[pounds sterling]GroupC[yen], the C[pounds sterling]CompanyC[yen] or C[pounds sterling]A&D PharmaC[yen]), the Dutch holding company that owns the largest integrated pharmaceutical wholesale, marketing and sales, and retail business in Romania, today announces its unaudited financial statements for the twelve months ended 31 December 2009 prepared in accordance with IFRS.